Unit of Geriatric Medicine, IRCCS INRCA, Cosenza, Italy.
Unit of Geriatric Pharmacoepidemiology and Biostatistics, IRCCS INRCA, Ancona and Cosenza, Italy.
Aging Clin Exp Res. 2021 Sep;33(9):2445-2451. doi: 10.1007/s40520-020-01755-1. Epub 2021 Jan 3.
Chronic kidney disease (CKD) is a common condition in older people and represents a global health issue since it increases the risk of associated comorbidities and all-cause mortality. Furthermore, older people with reduced renal function might be at higher risk for developing functional limitation and disability. Moreover, the current creatinine-based measures of renal function are influenced by several factors in older population. The aims of the CKD-3D project are to perform an observational study to expand the knowledge about CKD-disability relationship and to investigate the use of novel biomarkers of kidney function.
An observational, multicenter, prospective cohort study will be conducted in 75 + old patients consecutively admitted to acute care wards of geriatric medicine at participating hospitals. The study planned to enroll 440 patients undergoing clinical and laboratory evaluations at baseline and after 12 months. Face-to-face follow-up at 6 months and telephone follow-up at 3 and 9 months will be carried out. Comprehensive Geriatric Assessment (CGA) and the measurement of Cystatin C, Beta-Trace Protein and Beta2-Microglobulin levels will be included.
This study will provide useful information to prevent CKD-related disability by collecting real-life data over 1-year period. The combined approach of CGA and the investigation of innovative existing biomarkers will make it possible to develop new recommendations and guidelines for a patient-centered approach. It is believed that such a study may lead to an improvement of knowledge on CKD in elderly patients and may also have implications in daily clinical practice and in decision-making process.
慢性肾脏病(CKD)是老年人的常见病症,也是一个全球性的健康问题,因为它会增加相关合并症和全因死亡率的风险。此外,肾功能下降的老年人可能面临更高的功能受限和残疾风险。此外,目前基于肌酐的肾功能评估方法受到老年人中多种因素的影响。CKD-3D 项目的目的是进行一项观察性研究,以扩展对 CKD-残疾关系的认识,并研究新型肾功能生物标志物的应用。
一项观察性、多中心、前瞻性队列研究将在参与医院的老年医学急性护理病房连续收治的 75 岁以上患者中进行。该研究计划在基线和 12 个月时对 440 名接受临床和实验室评估的患者进行入组。将进行 6 个月的面对面随访和 3 个月和 9 个月的电话随访。将进行全面老年评估(CGA)和胱抑素 C、β-痕迹蛋白和β2-微球蛋白水平的测量。
这项研究将通过在 1 年期间收集真实数据,为预防 CKD 相关残疾提供有用信息。综合 CGA 方法和对创新现有生物标志物的研究将有可能为以患者为中心的方法制定新的建议和指南。人们相信,这样的研究可能会提高对老年患者 CKD 的认识,并可能对日常临床实践和决策过程产生影响。